摘要
目的:近年来,不同类型的微卫星不稳定性(MSI)指定的不稳定性升高在选定的四核苷酸重复微卫星改变”(EMAST)已在一些肿瘤的报道,但其临床意义尚不清楚。我们的目的是确定在EMAST关系,MSI和临床病理特征,包括肿瘤结果,结直肠癌(CRC)。 材料与方法:我们评估了100例散发性CRC进行手术,使用五个标记(把mycl1,d9s242,D20S85,d8s321,和d20s82)为MSI EMAST和贝塞斯达面板。对hMSH3、c-erbB2的免疫组织化学检测EGFR和胸苷酸合成酶进行。临床特点和预后的相关性进行了评估。 结果:我们确定了22个EMAST阳性肿瘤(22%)及32微星高(MSI-H)肿瘤(32%)。EMAST更频繁比结肠癌直肠癌(P = 0.033),和具有MSI-H表型相关(P<0.001),低表达的hMSH3(P = 0.004),与胸苷酸合成酶的表达(P = 0.006)。38 MSI-L肿瘤中只有一个(4.5%)显示EMAST。长期的肿瘤学结果从总体和无病生存率EMAST和非EMAST肿瘤之间的相似。 结论:EMAST更密切的关系比MSI-L和MSS状态稳定。EMAST的临床和分子特征在肿瘤位置不同,胸苷酸合成酶的表达,表达的MSI和hMSH3。我们的初步研究结果支持EMAST本作为一种新的潜在的分类器在CRC。
关键词: 大肠癌,EMAST、hMSH3、微卫星不稳定性,胸苷酸合成酶。
Current Molecular Medicine
Title:Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features
Volume: 16 Issue: 9
Author(s): H.S. Lee, K.U. Park, D.-W. Kim, M.H. lhn, W.H. Kim, A.N. Seo, H.E. Chang, S.K. Nam, S.Y. Lee, H.-K. Oh, S.-B. Kang
Affiliation:
关键词: 大肠癌,EMAST、hMSH3、微卫星不稳定性,胸苷酸合成酶。
摘要: Purpose: Recently, a different type of microsatellite instability (MSI) instability designated ‘elevated microsatellite alterations at selected tetranucleotide repeats’ (EMAST) has been reported in several neoplasms, but its clinical implications remain unclear. We aimed to determine the relationships among EMAST, MSI and clinicopathologic characteristics, including oncologic outcomes, in colorectal cancer (CRC).
Materials and Methods: We evaluated 100 sporadic CRC cases subjected to surgery using five markers (MYCL1, D9S242, D20S85, D8S321, and D20S82) for EMAST and the Bethesda panel for MSI status. Immunohistochemical detection of hMSH3, c-erbB2, EGFR and thymidylate synthase was performed. Clinical characteristics and prognostic relevance were assessed. Results: We identified 22 EMAST-positive tumors (22.0%) and 32 MSI-high (MSI-H) tumors (32.0%). EMAST was more frequent in colon cancer than rectal cancer (p=0.033), and associated with MSI-H phenotype (p<0.001), low expression of hMSH3 (p=0.004), and overexpression of thymidylate synthase (p=0.006). Among the 38 MSI-L tumors, only one (4.5%) showed EMAST. Long-term oncologic results in terms of overall and disease-free survival were similar between EMAST and non-EMAST tumors. Conclusion: EMAST is more closely related to MSI-H than MSI-L or MSS status. The clinical and molecular characteristics of EMAST were distinct in terms of tumor location, thymidylate synthase expression, MSI status and hMSH3 expression. Our preliminary findings support the utility of EMAST as a new potential classifier in CRC.Export Options
About this article
Cite this article as:
H.S. Lee, K.U. Park, D.-W. Kim, M.H. lhn, W.H. Kim, A.N. Seo, H.E. Chang, S.K. Nam, S.Y. Lee, H.-K. Oh, S.-B. Kang , Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161124103020
DOI https://dx.doi.org/10.2174/1566524016666161124103020 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer
Current Drug Targets Time Recall; Future Concept of Chronomodulating Chemotherapy for Cancer
Current Pharmaceutical Biotechnology Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research EDITORIAL (Thematic Issue: Special Thematic Issuue: Development of Biomarkers in Tumors of Digestive System Part I)
Anti-Cancer Agents in Medicinal Chemistry Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer
Current Cancer Drug Targets HDAC Inhibitors as Novel Anti-Cancer Therapeutics
Recent Patents on Anti-Cancer Drug Discovery Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?
Anti-Cancer Agents in Medicinal Chemistry Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy
Current Cancer Therapy Reviews Potential Benefits of Glitazones for Cancer and Vascular Disease
Current Drug Therapy A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy
Current Cancer Therapy Reviews Medicinal Chemistry of Antiviral/Anticancer Prodrugs Subjected to Phosphate Conjugation
Mini-Reviews in Medicinal Chemistry Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
Current Cancer Drug Targets From Adipose Tissue Protein Secretion to Adipopharmacology of Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Current Cancer Drug Targets Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells
Current Cancer Drug Targets Editorial [Hot Topic: QSAR Models for Computer-Aided Drug Design and Molecular Docking for Disorders of the Central Nervous System and Other Diseases]
Current Topics in Medicinal Chemistry Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry Selenium in the Prevention and Treatment of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Neovascular Age-related Macular Degeneration: Past, Present, and Future
Current Angiogenesis (Discontinued)